Abstract
Background Recurrent cardiac healthcare utilization (HCU) is common in patients with non-obstructive coronary artery disease (NOCAD), yet the long-term psychosocial and health-status determinants of care use remain insufficiently understood. Identifying these factors is essential for improving patient-centered management and reducing unnecessary diagnostic testing.
Methods In this 10-year prospective cohort study, 546 patients (52% women) with angiographically or CT-confirmed NOCAD were followed for emergency department (ED) visits for cardiac symptoms and repeat diagnostic cardiac tests. Baseline assessments included measures of mental health (anxiety, depressive symptoms, Type D personality) and health status (fatigue, generic and disease-specific quality of life). Negative binomial regression models examined associations between baseline psychosocial factors and total HCU, adjusting sequentially for age, sex, education, obesity, diabetes, and major adverse cardiovascular events (MACE). Sex-stratified and MACE-stratified exploratory analyses were performed.
Results Half of the cohort experienced at least one cardiac-related healthcare contact during follow-up. In age- and sex-adjusted models, higher baseline anxiety and fatigue, poorer physical health, greater angina frequency, and lower quality of life were associated with higher HCU. After full adjustment, lower baseline quality of life, diabetes, and subsequent MACE remained independent predictors of greater HCU. Sex-stratified analyses showed that more frequent angina and lower quality of life predicted HCU in women but not in men. Most patients with recurrent HCU did not develop MACE, indicating that persistent subjective symptom burden, rather than objective disease progression, drove long-term utilization.
Conclusions In patients with NOCAD, recurrent cardiac HCU is common and is independently predicted by baseline quality of life and cardiometabolic risk. Sex-specific psychosocial patterns contribute to care use, particularly among women. These findings highlight the need to integrate psychosocial assessment, symptom evaluation, and quality-of-life monitoring into routine care to optimize management and reduce recurrent healthcare utilization.
What Is Known
Recurrent cardiac healthcare utilization (HCU) is common in patients with non-obstructive coronary artery disease (NOCAD), even when objective disease progression is absent.
Symptom burden and psychosocial distress have been suggested as important drivers of healthcare-seeking behavior in this population.
What the Study Adds
Lower baseline quality of life independently predicts higher long-term HCU over a 10-year period.
Sex-specific patterns emerged, with angina frequency and poorer quality of life predicting recurrent HCU in women only.
Most recurrent care occurred without subsequent major adverse cardiovascular events, underscoring that subjective symptom burden—rather than disease progression—drives long-term utilization.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
NCT01788241
Funding Statement
This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study was conducted in accordance with the Declaration of Helsinki. Ethical approval was obtained from the institutional review board of METC Brabant (NL22258.008.08, amendment ETZ: L1160.2020/LP.2008.227), and all participants provided written informed consent prior to inclusion in the study.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data availability statement
The data underlying this article are available upon reasonable request to the corresponding author. The data are not publicly available due to privacy and ethical restrictions.
